SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-015342
Filing Date
2017-08-03
Accepted
2017-08-03 16:11:15
Documents
59
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q arwr-10q_20170630.htm 10-Q 1658653
2 EX-31.1 arwr-ex311_7.htm EX-31.1 10862
3 EX-31.2 arwr-ex312_9.htm EX-31.2 11276
4 EX-32.1 arwr-ex321_8.htm EX-32.1 6697
5 EX-32.2 arwr-ex322_6.htm EX-32.2 6914
  Complete submission text file 0001564590-17-015342.txt   5312175

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT arwr-20170630.xml EX-101.INS 801119
7 XBRL TAXONOMY EXTENSION SCHEMA arwr-20170630.xsd EX-101.SCH 43665
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arwr-20170630_cal.xml EX-101.CAL 49010
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arwr-20170630_def.xml EX-101.DEF 172882
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE arwr-20170630_lab.xml EX-101.LAB 393991
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arwr-20170630_pre.xml EX-101.PRE 311983
Mailing Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101
Business Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101 626-304-3400
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

IRS No.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-38042 | Film No.: 171005020
SIC: 2834 Pharmaceutical Preparations